Interleukin-7 Resensitizes Non-Small-Cell Lung Cancer to Cisplatin via Inhibition of ABCG2

Treatment with cisplatin (DDP) is one of the standard therapies used to treat non-small-cell lung cancer (NSCLC) and fundamentally causes resistance in cancer cells, which eventually poses as an obstacle to the efficacy of chemotherapy in NSCLC. Efforts are on all over the world to explore a sensiti...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Mediators Inflamm
Hauptverfasser: Ke, Bin, Wei, Ting, Huang, Yuanyuan, Gong, Yuxin, Wu, Gang, Liu, Junfang, Chen, Xiaoting, Shi, Lin
Format: Artigo
Sprache:Inglês
Veröffentlicht: Hindawi 2019
Schlagworte:
Research Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6931030/
https://ncbi.nlm.nih.gov/pubmed/31915416
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/7241418
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge